North America Clinical Trials Market Report 2023: Sector to Reach $39.26 Billion by 2031 at a 7.1% CAGR
Wednesday, May 17, 2023
DUBLIN, May 9, 2023 /PRNewswire/ -- The "North America Clinical Trials Market 2022-2031 by Product Category, Phase, Design, Service Type, Indication, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
North America clinical trials market is projected to grow by 7.1% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
This 178-page report is based on a comprehensive research of the entire North America clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
-- Market Structure
-- Growth Drivers
-- Restraints and Challenges
-- Emerging Product Trends & Market Opportunities
-- Porter's Five Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.
Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
-- Trials of Drugs
-- Small Molecule Drugs
-- Vaccines
-- Cell & Gene Therapy
-- Other Drugs
-- Trials of Devices
-- Trials of Procedures
Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
-- Phase I
-- Phase II
-- Phase III
-- Phase IV
By Design, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
-- Interventional Studies
-- Randomized Control Trial
-- Adaptive Clinical Trial
-- Non-randomized Control Trial
-- Observational Studies
-- Cohort Study
-- Case Control Study
-- Cross Sectional Study
-- Ecological Study
-- Expanded Access Trials
By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
-- Protocol Designing
-- Site Identification
-- Patient Recruitment
-- Laboratory Services
-- Bioanalytical Testing Services
-- Clinical Trial Data Management Services
-- Clinical Trial Supply & Logistic Services
-- Decentralized Clinical Trial Services
-- Medical Device Testing Services
-- Other Clinical Trial Services
By Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
-- Oncology
-- Infectious Diseases
-- Cardiology
-- Obesity
-- Diabetes
-- Neurology
-- Immunology
-- Pain Management
-- Other Indications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
-- Pharmaceutical and Biotechnological Companies
-- Clinical Research Organizations
-- Clinical Testing Laboratories
-- Other End Users
Geographically, the following national/local markets are fully investigated:
-- U.S.
-- Canada
-- Mexico
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of North America Market by Product Category
4 Segmentation of North America Market by Phase
5 Segmentation of North America Market by Design
6 Segmentation of North America Market by Service Type
7 Segmentation of North America Market by Indication
8 Segmentation of North America Market by End User
9 North America Market 2021-2031 by Country
10 Competitive Landscape
Companies Mentioned
-- Accell Clinical Research LLC
-- Charles River Laboratories
-- ClinDatrix Inc
-- Clinipace
-- Eli Lilly and Company
-- F. Hoffmann-La Roche Ltd.
-- ICON PLC
-- IQVIA Holdings, Inc.
-- Laboratory Corporation of America (Covance Inc.)
-- Novo Nordisk AS
-- PAREXEL International Corporation
-- Pfizer Inc.
-- Pharmaceutical Product Development LLC
-- PhlexNorth America
-- PRA Health Sciences
-- Sanofi SA
-- SGS SA (SGS Life Sciences)
-- Syneos Health Inc.
-- Wuxi AppTec Inc.
For more information about this report visit https://www.researchandmarkets.com/r/96kqy1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/north-america-clinical-trials-market-report-2023-sector-to-reach-39-26-billion-by-2031-at-a-7-1-cagr-301819906.html
SOURCE Research and Markets
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
StackGen Named in Four Gartner® Hype Cycles(TM) for Platform Engineering, Infrastructure Strategy, Site Reliability Engineering, and I&O Automation in 2025 | Jan 22, 2026
|
|
Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
|
|
|
